CASR and colorectal carcinoma: To date, no CaSR mutations have been associated with CRC risk or mortality, although there are suggestions that certain polymorphisms (including A986S, R990G, Q1011E) could be linked to CRC risk (Dong et al., 2008; Jacobs et al., 2010).